Aaron Weitzman

One Equity Partners’ investment in AdaptHealth, expanding the company’s offerings from sleep apnea to diabetes, is a perfect example of the firm’s creativeness.

Blackstone inks deal with PTC Therapeutics.

Thoma Bravo and Sunstone are acquiring UserTesting in a test-private deal for $1.3 billion.

Berkin adds nearly 20 years of experience transacting across mid-market healthcare.

‘Fragmented supply chain, sticky relationships lead to unique M&A opportunities in the medical device manufacturing space,’ said ICG’s Gregory.

Signets invests in LAXAI.

The combined firm’s offerings will include private capital, trusted advice and capital, credit, real estate and growth equity.

BDT and MSD merge to form new advisory and investment firm.

So far, Blucrest is three people, an idea and a capital commitment from GTCR.

The Chicago firm reportedly grew the target's EBITDA from $2m in 2017 to $70m when sold to Olympus Partners in September.